Apr 22 2015
Furthering its commitment to infection prevention, Broadlawns Medical Center (BMC) is proud to announce that a Xenex robot has been acquired to disinfect surgical suites, examination rooms, patient rooms and restrooms from potentially harmful pathogens and drug resistant organisms.
Broadlawns becomes one of the first hospitals in Iowa to incorporate this state-of-the-art technology into its disinfection protocol throughout the hospital.
The Xenex Germ-Zapping Robot™ emits xenon ultraviolet (UV-C) light that is 20,000 times more intense than sunlight to eradicate harmful bacteria, viruses, fungi and bacterial spores from exposed surface areas. The 3’ tall Xenex robot efficiently and effectively disinfects a patient room in 5-10 minutes. Independent clinical studies have shown statistically significant efficacy rates in the reduction of superbugs; most notably the Xenex robot has been proven to reduce MRSA and Clostridium difficile (C. diff) infections by more than 50 percent in healthcare facilities.
“Broadlawns is committed to providing a safe environment for patient care,” says Jaci Bell, Infection Control Coordinator for BMC. “We are excited to have this level of technology available to us as it will assist Broadlawns with our infection prevention efforts.”
Broadlawns Medical Center is a nonprofit healthcare organization that ensures our community is provided quality healthcare that is coordinated, compassionate and cost effective. The Broadlawns campus includes an acute care hospital, primary and specialty care clinics, urgent care and emergency services, lab, radiology, inpatient and outpatient mental health, dentistry, crisis team and community-based behavioral support services. Broadlawns accepts all forms of insurance and its approach to healthcare and quality outcomes earned a Level 3 rating from the National Committee for Quality Assurance (NCQA), the highest achievable status for a medical delivery model.
Source: http://www.xenex.com/